Literature DB >> 8225228

Membrane-associated C-reactive protein on rat liver macrophages is synthesized within the macrophages, expressed as neo-C-reactive protein and bound through a C-reactive protein-specific membrane receptor.

C Egenhofer1, K Alsdorff, K Fehsel, V Kolb-Bachofen.   

Abstract

We could recently show that rat liver macrophages (Kupffer cells) express a membrane-bound form of C-reactive protein on their surface. Because it is removed by washing the cells in buffers containing Ca(++)-chelators, membrane-bound C-reactive protein is a peripheral protein rather than an integral part of the Kupffer cell membrane. This Kupffer cell membrane-bound C-reactive protein is identical to the galactose-specific particle receptor previously characterized. We now present evidence that Kupffer cells do not acquire soluble serum C-reactive protein but synthesize their own membrane-bound C-reactive protein. By RNA-RNA in situ hybridization, it was found that hepatocytes are not the only sort of liver cells synthesizing C-reactive protein, but C-reactive protein-specific mRNA is present also in Kupffer cells. During acute-phase response C-reactive protein mRNA is found in increased amounts within liver macrophages too. Furthermore, by labeling experiments with antisera against native, pentameric soluble serum C-reactive protein and monoclonal antibodies against a neoepitope present on C-reactive protein subunits only, we could establish that the membrane-bound C-reactive protein expressed on the liver macrophage is not the pentameric molecule of soluble serum C-reactive protein, but rather consists of C-reactive protein subunits. Finally, we present evidence that liver macrophages contain a binding protein in their plasma membrane, with an apparent molecular weight of 59 to 61kD, specific for C-reactive protein and similar to the one previously isolated from macrophage cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225228

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.

Authors:  Ondrej Fiala; Milos Pesek; Jindrich Finek; Ondrej Topolcan; Jaroslav Racek; Marek Minarik; Lucie Benesova; Zbynek Bortlicek; Alexandr Poprach; Tomas Buchler
Journal:  Tumour Biol       Date:  2015-06-19

2.  Expression of C-reactive protein in the human respiratory tract.

Authors:  J M Gould; J N Weiser
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes.

Authors:  Toshinobu Nakatsu; Satoru Motoyama; Kiyotomi Maruyama; Shuetsu Usami; Yusuke Sato; Masatomo Miura; Yudai Hinai; Hajime Saito; Yoshihiro Minamiya; Katsuyuki Murata; Jun-ichi Ogawa
Journal:  Surg Today       Date:  2012-02-21       Impact factor: 2.549

4.  C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer.

Authors:  Azubuike I Okemefuna; Lasse Stach; Sudeep Rana; Akim J Ziai Buetas; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

5.  Expression of membrane-associated C-reactive protein by human monocytes: indications for a selectin-like activity participating in adhesion.

Authors:  V Kolb-Bachofen; N Puchta-Teudt; C Egenhofer
Journal:  Glycoconj J       Date:  1995-04       Impact factor: 2.916

Review 6.  Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis.

Authors:  Ying Huang; Ji-Feng Feng; Jin-Shi Liu; Qi-Xun Chen
Journal:  Ther Clin Risk Manag       Date:  2015-01-21       Impact factor: 2.423

Review 7.  Sialic acids in molecular and cellular interactions.

Authors:  S Kelm; R Schauer
Journal:  Int Rev Cytol       Date:  1997

8.  CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium.

Authors:  L Klein; T Klein; U Rüther; B Kyewski
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.